UBS AM’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q1 | – | Sell |
-115,894
| Closed | -$1.96M | – | 2688 |
|
|
2014
Q4 | $1.96M | Buy |
115,894
+14,000
| +14% | +$237K | ﹤0.01% | 1330 |
|
|
2014
Q3 | $1.22M | Buy |
101,894
+2,800
| +3% | +$33.4K | ﹤0.01% | 1493 |
|
|
2014
Q2 | $559K | Buy |
99,094
+22,300
| +29% | +$126K | ﹤0.01% | 1852 |
|
|
2014
Q1 | $282K | Buy |
76,794
+24,300
| +46% | +$89.2K | ﹤0.01% | 2222 |
|
|
2013
Q4 | $176K | Buy |
52,494
+9,600
| +22% | +$32.2K | ﹤0.01% | 2407 |
|
|
2013
Q3 | $182K | Hold |
42,894
| – | – | ﹤0.01% | 2362 |
|
|
2013
Q2 | $197K | Buy |
+42,894
| New | +$197K | ﹤0.01% | 2268 |
|